Larry Kociolek to Feces
This is a "connection" page, showing publications Larry Kociolek has written about Feces.
Connection Strength
1.224
-
Clostridioides difficile Whole-Genome Sequencing Reveals Limited Within-Host Genetic Diversity in a Pediatric Cohort. J Clin Microbiol. 2019 09; 57(9).
Score: 0.507
-
Identification of Clostridium innocuum hypothetical protein that is cross-reactive with C. difficile anti-toxin antibodies. Anaerobe. 2022 Jun; 75:102555.
Score: 0.152
-
Lack of false-positive results for Clostridioides difficile toxins A and B using two commercial enzyme immunoassays in pediatric patients. Infect Control Hosp Epidemiol. 2019 07; 40(7):825-826.
Score: 0.124
-
Strategies for Optimizing the Diagnostic Predictive Value of Clostridium difficile Molecular Diagnostics. J Clin Microbiol. 2017 05; 55(5):1244-1248.
Score: 0.107
-
Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients. Antimicrob Agents Chemother. 2016 08; 60(8):4896-900.
Score: 0.102
-
Clinical Utility of Laboratory Detection of Clostridium difficile Strain BI/NAP1/027. J Clin Microbiol. 2016 Jan; 54(1):19-24.
Score: 0.097
-
Redefining Clostridioides difficile infection antibiotic response and clinical outcomes. Lancet Infect Dis. 2023 07; 23(7):e259-e265.
Score: 0.041
-
Stool Toxin Concentration Does Not Distinguish Clostridioides difficile Infection from Colonization in Children Less Than 3 Years of Age. J Pediatric Infect Dis Soc. 2022 Oct 25; 11(10):454-458.
Score: 0.039
-
Safety and Pharmacokinetic Study of Fidaxomicin in Children With Clostridium difficile-Associated Diarrhea: A Phase 2a Multicenter Clinical Trial. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):210-218.
Score: 0.030
-
Clostridium difficile-Diagnostic and Clinical Challenges. Clin Chem. 2016 Feb; 62(2):310-4.
Score: 0.025